DNA nanocarriers for systemic administration: Characterization and in vivo bioimaging in healthy mice

Molecular Therapy Nucleic Acids

Volumn 2, Issue , 2013, Pages e64-

  David, Stephanie ^a,b,c   Passirani, Catherine ^a,b   Carmoy, Nathalie ^d   Morille, Marie ^a,b   Mevel, Mathieu ^c   Chatin, Benoit ^c   Benoit, Jean Pierre ^a,b   Montier, Tristan ^d   Pitard, Bruno ^c,e  

^a UNIVERSITÉ D'ANGERS   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c L INSTITUT DU THORAX   (France)

^d FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

^e In Cell Art   (France)

Author keywords

ABC phenomenon; Lipid nanocapsules; Multimodular systems; Repeated administration; Targeting

Indexed keywords

ASIALOGLYCOPROTEIN RECEPTOR; BIS (GUANIDINIUM) TREN CHOLESTEROL; CHOLESTEROL; DNA; FLUORESCENT DYE; GALACTOSE; IOLEYLAMINESUCCINYLPAROMOMYCIN; MACROGOL; NANOCAPSULE; NANOCARRIER; PAROMOMYCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BIOFLUORESCENCE IMAGING; CIRCULATION; CONTROLLED STUDY; ENCAPSULATION; FLUORESCENCE IMAGING; IN VIVO STUDY; LIVER TOXICITY; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; ZETA POTENTIAL;

EID: 84878818948     PISSN: None     EISSN: 21622531     Source Type: Journal    
DOI: 10.1038/mtna.2012.56     Document Type: Article

References (37)

1. Viola, JR, El-Andaloussi, S, Oprea, II and Smith, CI (2010). Non-viral nanovectors for gene delivery: factors that govern successful therapeutics. Expert Opin Drug Deliv 7: 721-735.
2. Vonarbourg, A, Passirani, C, Desigaux, L, Allard, E, Saulnier, P, Lambert, O et al. (2009). The encapsulation of DNA molecules within biomimetic lipid nanocapsules. Biomaterials 30: 3197-3204.
3. Heurtault, B, Saulnier, P, Pech, B, Proust, JE and Benoit, JP (2002). A novel phase inversion- based process for the preparation of lipid nanocarriers. Pharm Res 19: 875-880. (Pubitemid 34692585)
4. Morille, M, Passirani, C, Letrou-Bonneval, E, Benoit, JP and Pitard, B (2009). Galactosylated DNA lipid nanocapsules for efficient hepatocyte targeting. Int J Pharm 379: 293-300.
5. Morille, M, Montier, T, Legras, P, Carmoy, N, Brodin, P, Pitard, B et al. (2010). Longcirculating DNA lipid nanocapsules as new vector for passive tumor targeting. Biomaterials 31: 321-329.
6. Morille, M, Passirani, C, Dufort, S, Bastiat, G, Pitard, B, Coll, JL et al. (2011). Tumor transfection after systemic injection of DNA lipid nanocapsules. Biomaterials 32: 2327- 2333.
7. Letrou-Bonneval, E, Chèvre, R, Lambert, O, Costet, P, André, C, Tellier, C et al. (2008). Galactosylated multimodular lipoplexes for specific gene transfer into primary hepatocytes. J Gene Med 10: 1198-1209.
8. Waerzeggers, Y, Monfared, P, Viel, T, Winkeler, A, Voges, J and Jacobs, AH (2009). Methods to monitor gene therapy with molecular imaging. Methods 48: 146-160.
9. Pitard, B (2002). Supramolecular assemblies of DNA delivery systems. Somat Cell Mol Genet 27: 5-15.
10. Felgner, PL, Barenholz, Y, Behr, JP, Cheng, SH, Cullis, P, Huang, L et al. (1997). Nomenclature for synthetic gene delivery systems. Hum Gene Ther 8: 511-512. (Pubitemid 27202042)
11. Vonarbourg, A, Saulnier, P, Passirani, C and Benoit, JP (2005). Electrokinetic properties of noncharged lipid nanocapsules: influence of the dipolar distribution at the interface. Electrophoresis 26: 2066-2075. (Pubitemid 40852638)
12. Hilderbrand, SA and Weissleder, R (2010). Near-infrared fluorescence: application to in vivo molecular imaging. Curr Opin Chem Biol 14: 71-79.
13. David, S, Carmoy, N, Resnier, P, Denis, C, Misery, L, Pitard, B et al. (2012). In vivo imaging of DNA lipid nanocapsules after systemic administration in a melanoma mouse model. Int J Pharm 423: 108-115.
14. Goutayer, M, Dufort, S, Josserand, V, Royère, A, Heinrich, E, Vinet, F et al. (2010). Tumor targeting of functionalized lipid nanoparticles: assessment by in vivo fluorescence imaging. Eur J Pharm Biopharm 75: 137-147.
15. Texier, I, Goutayer, M, Da Silva, A, Guyon, L, Djaker, N, Josserand, V et al. (2009). Cyanine- loaded lipid nanoparticles for improved in vivo fluorescence imaging. J Biomed Opt 14: 054005.
16. Dufort, S, Sancey, L, Wenk, C, Josserand, V and Coll, JL (2010). Optical small animal imaging in the drug discovery process. Biochim Biophys Acta 1798: 2266-2273.
17. Schwartz, AL (1984). The hepatic asialoglycoprotein receptor. CRC Crit Rev Biochem 16: 207-233.
18. Steirer, LM, Park, EI, Townsend, RR and Baenziger, JU (2009). The asialoglycoprotein receptor regulates levels of plasma glycoproteins terminating with sialic acid alpha2,6-galactose. J Biol Chem 284: 3777-3783.
19. Choi, HS, Liu, W, Misra, P, Tanaka, E, Zimmer, JP, Itty Ipe, B et al. (2007). Renal clearance of quantum dots. Nat Biotechnol 25: 1165-1170. (Pubitemid 47538116)
20. Semple, SC, Harasym, TO, Clow, KA, Ansell, SM, Klimuk, SK and Hope, MJ (2005). Immunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic Acid. J Pharmacol Exp Ther 312: 1020-1026. (Pubitemid 40293760)
21. Judge, A, McClintock, K, Phelps, JR and Maclachlan, I (2006). Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomes. Mol Ther 13: 328-337. (Pubitemid 43056898)
22. Tagami, T, Nakamura, K, Shimizu, T, Yamazaki, N, Ishida, T and Kiwada, H (2010). CpG motifs in pDNA-sequences increase anti-PEG IgM production induced by PEG-coated pDNA-lipoplexes. J Control Release 142: 160-166.
23. Laverman, P, Carstens, MG, Boerman, OC, Dams, ET, Oyen, WJ, van Rooijen, N et al. (2001). Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection. J Pharmacol Exp Ther 298: 607-612. (Pubitemid 32673411)
24. Ishida, T, Ichihara, M, Wang, X and Kiwada, H (2006). Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes. J Control Release 115: 243-250. (Pubitemid 44634842)
25. Mosier, DE and Subbarao, B (1982). Thymus-independent antigens: complexity of B-lymphocyte activation revealed. Immunol Today 3: 217-222.
26. Peng, SL (2005). Signaling in B cells via Toll-like receptors. Curr Opin Immunol 17: 230-236. (Pubitemid 40692656)
27. Jego, G, Palucka, AK, Blanck, JP, Chalouni, C, Pascual, V and Banchereau, J (2003). Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 19: 225-234. (Pubitemid 37011337)
28. Poeck, H, Wagner, M, Battiany, J, Rothenfusser, S, Wellisch, D, Hornung, V et al. (2004). Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help. Blood 103: 3058-3064. (Pubitemid 38451681)
29. Aschenbrenner, K, D'Cruz, LM, Vollmann, EH, Hinterberger, M, Emmerich, J, Swee, LK et al. (2007). Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells. Nat Immunol 8: 351-358. (Pubitemid 46745410)
30. Peçanha, LM, Snapper, CM, Lees, A, Yamaguchi, H and Mond, JJ (1993). IL-10 inhibits T cell-independent but not T cell-dependent responses in vitro. J Immunol 150(8 Pt 1): 3215-3223. (Pubitemid 23129700)
31. David, S, Montier, T, Carmoy, N, Resnier, P, Clavreul, A, Mével, M et al. (2012). Treatment efficacy of DNA lipid nanocapsules and DNA multimodular systems after systemic administration in a human glioma model. J Med (doi:10.1002/jgm.2683).
32. Ishida, T, Masuda, K, Ichikawa, T, Ichihara, M, Irimura, K and Kiwada, H (2003). Accelerated clearance of a second injection of PEGylated liposomes in mice. Int J Pharm 255: 167-174. (Pubitemid 36369600)
33. Ishihara, T, Maeda, T, Sakamoto, H, Takasaki, N, Shigyo, M, Ishida, T et al. (2010). Evasion of the accelerated blood clearance phenomenon by coating of nanoparticles with various hydrophilic polymers. Biomacromolecules 11: 2700-2706.
34. Desigaux, L, Sainlos, M, Lambert, O, Chevre, R, Letrou-Bonneval, E, Vigneron, JP et al. (2007). Self-assembled lamellar complexes of siRNA with lipidic aminoglycoside derivatives promote efficient siRNA delivery and interference. Proc Natl Acad Sci USA 104: 16534-16539. (Pubitemid 350211053)
35. Vigneron, JP, Oudrhiri, N, Fauquet, M, Vergely, L, Bradley, JC, Basseville, M et al. (1996). Guanidinium-cholesterol cationic lipids: efficient vectors for the transfection of eukaryotic cells. Proc Natl Acad Sci USA 93: 9682-9686. (Pubitemid 26296669)
36. Garcion, E, Lamprecht, A, Heurtault, B, Paillard, A, Aubert-Pouessel, A, Denizot, B et al. (2006). A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats. Mol Cancer Ther 5: 1710-1722. (Pubitemid 44323239)
37. Hem, A, Smith, AJ and Solberg, P (1998). Saphenous vein puncture for blood sampling of the mouse, rat, hamster, gerbil, guinea pig, ferret and mink. Lab Anim 32: 364-368. (Pubitemid 28482470)